Research shows that there is a strong association between rates of transition from substance use to substance use disorder and the lifetime risk for mental illness, particularly personality and psychotic disorders.
[More]
Itchy eyes, scratchy throat, running nose--it's allergy season! What triggers these allergic reactions, and how do allergy medications work?
[More]
Researchers from the Perelman School of Medicine at University of the Pennsylvania have shown that an area of the brain that initiates behavioral changes had greater activation in smokers who watched anti-smoking ads with strong arguments versus those with weaker ones, and irrespective of flashy elements, like bright and rapidly changing scenes, loud sounds and unexpected scenario twists.
[More]
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has started a Phase II proof of concept study with CNV2197944 in pain associated with post-herpetic neuralgia.
[More]
In their article "Over 30 million psychedelic users in the United States", Teri S Krebs and P-l--rjan Johansen from the Department of Neuroscience at Norwegian University of Science and Technology, use data from a randomly-selected sample of over 57,000 individuals surveyed for the 2010 National Survey on Drug Use and Health, to estimate lifetime prevalence of psychedelic use.
[More]
New, nationally projectable survey results released today by The Partnership at Drugfree.org and MetLife Foundation confirmed that one in four teens has misused or abused a prescription (Rx) drug at least once in their lifetime - a 33 percent increase over the past five years.
[More]
Biological Psychiatry is proud to announce this week's publication of a special issue focusing on the question of food as an addiction.
[More]
Alkermes plc (NASDAQ: ALKS) today announced positive preliminary topline results from a phase 2 study of ALKS 5461, its novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.
[More]
Jewish leaders and members of the public will explore the connections between Jewish wisdom and wellness during a community-wide "week of learning" devoted to a variety of notable subjects, including the influence of Jewish tradition on end-of-life decisions, yoga as a healing art and the Jewish perspective on organ transplantation.
[More]
For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.
[More]
Smoking tobacco through a hookah is a pastime gaining popularity among the college crowd, but many of them mistakenly believe that using the fragrant water pipe is less harmful than smoking cigarettes.
[More]
ADial Pharmaceuticals, LLC, announced today that the U.S. Food and Drug Administration has agreed to allow ADial to move forward with its plan to initiate Phase III trials of AD04 as a treatment for alcohol use disorder in certain targeted genotypes population only.
[More]
Do people get caught in the cycle of overeating and drug addiction because their brain reward centers are over-active causing them to experience greater cravings for food or drugs? In a unique prospective study Oregon Research Institute senior scientist Eric Stice, Ph.D., and colleagues tested this theory, called the reward surfeit model.
[More]
News outlets report on a variety of implementation issues, including the question of how to provide treatment for the millions of people with addiction and alcohol dependencies who will have insurance for the first time and the difficulties faced by safety-net hospitals.
[More]
Today's headlines include reports about a new study finding that surgical woes can actually bolster a hospital's profits.
[More]
Using a miniature electronic device implanted in the brain, scientists have tapped into the internal reward system of mice, prodding neurons to release dopamine, a chemical associated with pleasure.
[More]
Estrogen and progesterone receptors, and the gene HER2 - these are the big three markers and/or targets in breast cancer. Evidence presented at the AACR Annual Meeting 2013 adds a fourth: androgen receptors.
[More]
President Obama will release his overdue budget on Wednesday. It will doubtless project a reduction in the federal budget deficit-;a projection that journalists, commentators and policy makers should ignore.
[More]
A new national public opinion poll commissioned by Research!America shows only 18% of respondents believe chronic pain is a major health problem, even though a majority of Americans (63%) say they know someone who experienced pain so severe that they sought prescription medicines to treat it.
[More]
Weill Cornell Medical College has established the new Feil Family Brain and Mind Research Institute, a unique, multidisciplinary translational neuroscience research hub. Named in honor of long-time benefactors Gertrude and Louis Feil, the institute was created with a generous $28 million gift from the Feil Family.
[More]